Certolizumab pegol , sold under the brand name Cimzia , is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) a...
Cimzia (certolizumab pegol) is a prescription injection that treats Crohn’s disease, arthritis, and other conditions. Learn about side effects, dosage, and more.
Find patient medical information for Cimzia (certolizumab pegol) on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
This sheet is about exposure to certolizumab pegol in pregnancy and while breastfeeding. This information is based on available published literature. It should not take the place of medical care an...
CIMZIA is a biologic treatment for multiple chronic inflammatory conditions. Learn more about treatments, important safety information, and whether you're eligible for CIMZIA with $0 co-pay. See full prescribing information including boxed warning on serious infections.
This sheet is about exposure to certolizumab pegol in pregnancy and while breastfeeding. This information is based on available published literature. It should not take the place of medical care an...
Cimzia라는 상표명으로 판매되는 Certolizumab pegol은 크론병, 류마티스성 관절염, 시뇨관절염, 혈관확장성 척추염 등의 치료를 위한 생물학적 약물이다. 종양 괴사 인자 알파(TNF-α)에 특화된 단클론 항체의 파편이며 UCB가 제조한다. 그것은 세계보건기구의 필수 의약품 목록에 올라 있다. Certolizumab pegol은 종양 괴사
The objective of this review is to perform a systematic review of the beneficial and harmful effects of certolizumab pegol (CZP) for the treatment of active ankylosing spondylitis (AS) in adults wh...
Advice for mothers using Certolizumab Pegol (Cimzia) while breastfeeding. Includes possible effects on breastfed infants and lactation.
Certolizumab pegol (Cimzia(®)) is currently the only PEGylated anti-TNFα biologic approved for the treatment of rheumatoid arthritis and Crohn disease. The product, developed by UCB, is a humanized...